期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | NEW ENGLAND JOURNAL OF MEDICINE LetPub Score 10.0
50 ratings
Rate
Reputation 10.0 Influence 10.0 Speed 9.5 | ||||||||||||||||
期刊簡稱 | NEW ENGL J MED | ||||||||||||||||
ISSN | 0028-4793 | ||||||||||||||||
E-ISSN | 1533-4406 | ||||||||||||||||
h-index | 933 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 0.60%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | http://www.nejm.org/ | ||||||||||||||||
在線稿件提交 | http://www.nejm.org/page/author-center/home | ||||||||||||||||
開放訪問 | No | ||||||||||||||||
出版商 | Massachussetts Medical Society | ||||||||||||||||
主題領域 | 医学 | ||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||
發行頻率 | 週刊 | ||||||||||||||||
創刊年 | 0 | ||||||||||||||||
每年文章數 | 300每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 3.80% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0028-4793%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 1 Month(s) | ||||||||||||||||
競爭力 * | 來自作者的數據: About 8.75% | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 | |
[NEW ENGLAND JOURNAL OF MEDICINE] 的評論 | 撰寫評論 |
作者: 王子的爸爸 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-05 12:17:10 評論於 How long does it take to submit an Image column with the editor now? The instructions say it will be rejected within a week. I submitted one before, and it was rejected on the 7th day. It has been 24 days since I submitted this one with the editor. Is there a new policy? Please let me know if anyone has any experience(0) 讚! | 王子的爸爸 |
作者: 百花倚轩 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-26 15:20:51 評論於 OP, what's the situation?(0) 讚! | 百花倚轩 |
作者: 玉萧夜露 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-04 21:12:27 評論於 The status is still in the hands of the editor, not sure when it will change(0) 讚! | 玉萧夜露 |
作者: 新柔超级甜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-04 13:05:28 評論於 How is the battle going?(0) 讚! | 新柔超级甜 |
作者: 玉萧夜露 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-28 09:02:13 評論於 Research focus: Clinical research; randomized controlled trials; sharing clinical experiences: Just submitted an image article, reviewed by the editor on the same day, currently 5 days(0) 讚! | 玉萧夜露 |
作者: 深渊诗柳 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-20 13:01:59 評論於 Focused research direction: Clinical research; Experience sharing on randomized controlled trials: Can effectively accept(0) 讚! | 深渊诗柳 |
作者: 飞月元洲 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-26 08:23:32 評論於 Any news?(0) 讚! | 飞月元洲 |
作者: Yves Harrison 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-06 11:58:16 評論於 How are your comrades doing? Can you share?(0) 讚! | Yves Harrison |
作者: 白云映儿 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-29 12:53:39 評論於 23.12.17 submission of picture with the editor, more than one month(0) 讚! | 白云映儿 |
作者: 西域慕凝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-09 08:41:13 評論於 Focus of Research: Clinical research experience sharing: Submitted a letter regarding a specific paper on November 7, 2023, hoping for a positive outcome(0) 讚! | 西域慕凝 |
作者: yyyylei 領域: 医学 審稿時間: 2.0 month(s) 結果: 直接被接受 撰寫評論 |
2023-09-27 16:50:11 評論於 How can I win?(0) 讚! | yyyylei |
作者: 北风安天 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-22 10:24:14 評論於 Me too, why is it so slow?(0) 讚! | 北风安天 |
作者: 月河香芹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-14 16:48:33 評論於 Review speed: 3.0 | Submission hit rate: 5.0 Emphasis on research direction: Sharing experience in randomized controlled trials: Clinical articles with standardized multicenter large samples are relatively easier to be accepted(0) 讚! | 月河香芹 |
作者: 七伤娴静 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-06 17:15:00 評論於 Any news yet?(0) 讚! | 七伤娴静 |
作者: 是志丹吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-29 20:57:55 評論於 Review speed: 3.0 | Submission acceptance rate: 5.0 Emphasized research areas: oncology; integrative medicine; cardiovascular Experience sharing: impact factor 158.5 points, slightly lower than Lancet's 168.9, due to fewer COVID-19 articles published in NEJM and slightly lower citation rates. Definitely surpass Lancet next year(0) 讚! | 是志丹吖 |
作者: 是志丹吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-29 13:03:01 評論於 Please translate the following paragraph into English and Japanese, and title them as ":" and ":" 正常(0) 讚! | 是志丹吖 |
作者: 骏俊来了 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-21 10:26:58 評論於 How long does it take to be published after submission?(0) 讚! | 骏俊来了 |
作者: 代芹姑娘 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-11 17:32:32 評論於 How long does it take for the letter to arrive in the end?(0) 讚! | 代芹姑娘 |
作者: 代芹姑娘 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-11 08:40:03 評論於 How long will it take for the letter to arrive?(0) 讚! | 代芹姑娘 |
作者: 折梅音仪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-30 14:08:23 評論於 How did it go? Submitted a clinical problem-solving article, but it is still in Administrative Screening a week later(0) 讚! | 折梅音仪 |
作者: 是志丹吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-19 19:42:33 評論於 #New England Journal of Medicine# supports this prediction(0) 讚! | 是志丹吖 |
作者: 云纵博远 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-17 11:38:46 評論於 Hello teacher, could you provide a more specific timeframe? It has been three weeks since I submitted and it has been With the Editor all this time(0) 讚! | 云纵博远 |
作者: 坠星倩影 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-03 17:40:02 評論於 Also worthy of a thumbs up(0) 讚! | 坠星倩影 |
作者: 坠星倩影 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-03 09:23:47 評論於 Should be successful(0) 讚! | 坠星倩影 |
作者: 坠星倩影 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-02 13:07:52 評論於 Review speed: 2.0 | Submission success rate: 5.0 Emphasized research directions: Clinical research; Clinical medicine; Randomized controlled trials Experience sharing: It is possible to break through 8 articles on NEJM in China in 2023! More than 10 articles in 2025, more than 10 articles every year thereafter, and can reach 20 articles every year by 2030! In fact, NEJM publishes just over 100 articles each year(0) 讚! | 坠星倩影 |
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 |
Contact us